Literature DB >> 17913821

Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.

Melody G Duvall1, Karin Loré, Hetty Blaak, David A Ambrozak, William C Adams, Kathlyn Santos, Christof Geldmacher, John R Mascola, Andrew J McMichael, Assan Jaye, Hilton C Whittle, Sarah L Rowland-Jones, Richard A Koup.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection of dendritic cells (DCs) has been documented in vivo and may be an important contributor to HIV-1 transmission and pathogenesis. HIV-1-specific CD4(+) T cells respond to HIV antigens presented by HIV-1-infected DCs and in this process become infected, thereby providing a mechanism through which HIV-1-specific CD4(+) T cells could become preferentially infected in vivo. HIV-2 disease is attenuated with respect to HIV-1 disease, and host immune responses are thought to be contributory. Here we investigated the susceptibility of primary myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) to infection by HIV-2. We found that neither CCR5-tropic primary HIV-2 isolates nor a lab-adapted CXCR4-tropic HIV-2 strain could efficiently infect mDCs or pDCs, though these viruses could infect primary CD4(+) T cells in vitro. HIV-2-exposed mDCs were also incapable of transferring virus to autologous CD4(+) T cells. Despite this, we found that HIV-2-specific CD4(+) T cells contained more viral DNA than memory CD4(+) T cells of other specificities in vivo. These data suggest that either infection of DCs is not an important contributor to infection of HIV-2-specific CD4(+) T cells in vivo or that infection of DCs by HIV-2 occurs at a level that is undetectable in vitro. The frequent carriage of HIV-2 DNA within HIV-2-specific CD4(+) T cells, however, does not appear to be incompatible with preserved numbers and functionality of HIV-2-specific CD4(+) T cells in vivo, suggesting that additional mechanisms contribute to maintenance of HIV-2-specific CD4(+) T-cell help in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913821      PMCID: PMC2168847          DOI: 10.1128/JVI.00976-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

Authors:  Stuart G Turville; John J Santos; Ines Frank; Paul U Cameron; John Wilkinson; Monica Miranda-Saksena; Joanne Dable; Hella Stössel; Nikolaus Romani; Michael Piatak; Jeffrey D Lifson; Melissa Pope; Anthony L Cunningham
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.

Authors:  Hetty Blaak; Marchina E van der Ende; Patrick H M Boers; Hanneke Schuitemaker; Albert D M E Osterhaus
Journal:  Virology       Date:  2006-06-30       Impact factor: 3.616

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

4.  Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection.

Authors:  M Zaitseva; A Blauvelt; S Lee; C K Lapham; V Klaus-Kovtun; H Mostowski; J Manischewitz; H Golding
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

5.  Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.

Authors:  M Pope; S S Frankel; J R Mascola; A Trkola; F Isdell; D L Birx; D S Burke; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

Authors:  P U Cameron; P S Freudenthal; J M Barker; S Gezelter; K Inaba; R M Steinman
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

7.  Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.

Authors:  Jean-François Fonteneau; Marie Larsson; Anne-Sophie Beignon; Kelli McKenna; Ida Dasilva; Ali Amara; Yong-Jun Liu; Jeffrey D Lifson; Dan R Littman; Nina Bhardwaj
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

10.  Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

Authors:  Florian Hladik; Polachai Sakchalathorn; Lamar Ballweber; Gretchen Lentz; Michael Fialkow; David Eschenbach; M Juliana McElrath
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

View more
  20 in total

1.  Biology of HIV mucosal transmission.

Authors:  Li Wu
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

2.  Restricting HIV the SAMHD1 way: through nucleotide starvation.

Authors:  Diana Ayinde; Nicoletta Casartelli; Olivier Schwartz
Journal:  Nat Rev Microbiol       Date:  2012-08-28       Impact factor: 60.633

Review 3.  Myeloid dendritic cells in HIV-1 infection.

Authors:  Nina Derby; Elena Martinelli; Melissa Robbiani
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

4.  HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels.

Authors:  Lise Chauveau; Daniel Aaron Donahue; Blandine Monel; Francoise Porrot; Timothée Bruel; Lea Richard; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS.

Authors:  Thangavel Samikkannu; Kurapati V K Rao; Nimisha Gandhi; Shailendra K Saxena; Madhavan P N Nair
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

6.  Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes.

Authors:  Helena Nunes-Cabaço; Paula Matoso; Russell B Foxall; Rita Tendeiro; Ana R Pires; Tânia Carvalho; Ana I Pinheiro; Rui S Soares; Ana E Sousa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.

Authors:  Suzanne D G Kijewski; Hisashi Akiyama; Amin Feizpour; Caitlin M Miller; Nora-Guadalupe P Ramirez; Björn M Reinhard; Suryaram Gummuluru
Journal:  Virology       Date:  2016-08-11       Impact factor: 3.616

8.  SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells.

Authors:  Isabel Puigdomènech; Nicoletta Casartelli; Françoise Porrot; Olivier Schwartz
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

Review 9.  HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.

Authors:  Christopher M Coleman; Li Wu
Journal:  Retrovirology       Date:  2009-06-01       Impact factor: 4.602

10.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.